secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001654954-26-002304
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica reports record Q4 revenue $10.5M, full-year revenue $32.0M (+17% YoY)
------------------------------------------------------------------------------

- Q4 revenue $10.5M (+33% YoY); full year $32.0M (+17%). Record 20th straight YoY increase.
- Gross margin 68% for year; Q4 69% best quarter. Adjusted EBITDA loss improved to $17.1M from $20.2M.
- Cash burn reduced to $18.1M for year, $1.1M in Q4; cash/securities $53.3M.
- Consumable revenue grew 16% to $20.7M; Development Services segment contributed $3.1M.
- Net loss $81.9M includes $55.8M non-cash impairment; operating expenses ex-impairment down 7%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495426002304/0001654954-26-002304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495426002304/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-26-002304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer